SI
AGN

Stephens Inc’s Allergan plc AGN Stock Holding History

Stephens Inc’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,363
Closed -$2.9M – 1219
2020
Q1 		$2.9M Sell
16,363
-763
-4% -$144K 0.08% 268
2019
Q4 		$3.27M Sell
17,126
-1,795
-9% -$324K 0.07% 307
2019
Q3 		$3.18M Sell
18,921
-3,639
-16% -$593K 0.07% 293
2019
Q2 		$3.78M Sell
22,560
-1,822
-7% -$252K 0.09% 263
2019
Q1 		$3.57M Buy
24,382
+1,248
+5% +$181K 0.08% 279
2018
Q4 		$3.09M Buy
23,134
+203
+0.9% +$33.3K 0.09% 271
2018
Q3 		$4.37M Sell
22,931
-588
-3% -$108K 0.11% 228
2018
Q2 		$3.92M Sell
23,519
-7,047
-23% -$1.13M 0.12% 206
2018
Q1 		$5.14M Buy
30,566
+5,960
+24% +$1,000K 0.19% 134
2017
Q4 		$4.03M Sell
24,606
-3,602
-13% -$646K 0.15% 163
2017
Q3 		$5.78M Buy
+28,208
New +$6.56M 0.21% 112
2015
Q2 		– Sell
-5,479
Closed -$1.63M – 858
2015
Q1 		$1.63M Buy
5,479
+2,260
+70% +$644K 0.07% 269
2014
Q4 		$829K Buy
3,219
+1,250
+63% +$312K 0.04% 385
2014
Q3 		$475K Buy
+1,969
New +$441K 0.02% 494

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Stephens Inc's AGN Position: Q2 2020 in Review

Stephens Inc sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 16,363 shares — an estimated $2.9M sold.

Stephens Inc first reported a position in AGN in Q3 2014 and held it in 14 quarters. The position peaked at $5.78M in Q3 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Stephens Inc reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Stephens Inc sold 16,363 Allergan plc shares in Q2 2020, an estimated $2.9M.
  • Stephens Inc first reported a position in Allergan plc in Q3 2014 and held it in 14 quarters.
  • Stephens Inc's Allergan plc position peaked at $5.78M in Q3 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Stephens Inc's 13F filing for Q2 2020, filed 24 Aug 2020.